10.03.17 CXR Biosciences

Research carried out at Concept Life Sciences (formerly CXR Biosciences), the investigative & exploratory toxicology company, is being presented in two posters at the upcoming Society Of Toxicology (SOT) 2017 annual meeting in Baltimore on 12th – 16th March.  This mechanistic research has been performed in partnership with Endura SpA, Science Strategies LLC and Honeywell. […]


Concept Life Sciences Group, the business formed in 2014 to break into the international Discovery & Development and Analytical markets, has announced its intention to significantly increase its investment in laboratory capacity and scientific staff. Michael Fort, Concept’s Executive Chairman said “The last two years has seen our company successfully integrate its acquired businesses and […]

04.11.16 CXR Biosciences

CXR Biosciences, part of the Concept Life Sciences Group, has been crowned winner of the ‘Science and Technology Business of the Year’ award at The Courier Business Awards for the second year running. The award was presented to the company on Saturday 29th October at an official awards ceremony which was held at The Apex […]


CXR Biosciences, part of the Concept Life Sciences Group, held its second Scientific Advisory Board recently which focused on the mechanistic toxicology services required by the agrochemical, chemical, pharmaceutical and consumer products industries. CXR brought together experienced investigative toxicologists from across the various target industries to debate industry needs and emerging trends and how CXR […]


CLIFF ELCOMBE OBITUARY Dr Cliff Elcombe was a well-known and accomplished British toxicologist, who spent almost his entire career investigating the mechanisms of toxicity of various industrial chemicals and agrochemicals.  He had an enviable reputation for his knowledge of, and insight into, non-genotoxic mechanisms of carcinogenesis and was internationally recognized for his work in predicting […]

30.08.16 CXR Biosciences

It is with great sadness that we learned that our colleague Dr Cliff Elcombe died suddenly last Thursday, 25th August after a short illness. Cliff was co-founder and Research Director of CXR, and an internationally renowned toxicologist. Cliff played a huge role in the formation and success of CXR, as well as in the wider […]


Professor Brian G Lake, BSc, PhD, DSc, FBTS has joined CXR Biosciences as an Associate Toxicologist. CXR Biosciences offers tailored preclinical services in the areas of investigative and mechanistic toxicology, exploratory and discovery toxicology, PK and metabolism and dermal absorbtion. Using its collaborative approach and industry expertise, CXR works with clients of all sizes to […]


CXR Biosciences, part of the Concept Life Sciences Group, has added in vitro dermal absorption studies to their already comprehensive portfolio of mechanistic toxicology and ADMET services.  This is also the first service that CXR offers to formal Good Laboratory Practice (GLP) standards, following a successful audit by the MHRA on 23rd June. The purpose […]

Royal Society - Kohn Centre 2

CXR Biosciences and Peakdale Molecular (members of the Concept Life Sciences Group) brought together a number of eminent speakers recently as part of their Spotlight Session series. The event, which was held at the Kohn Centre at the Royal Society in London focussed on current challenges in integrating safety testing into early drug, agrochemical and […]


CXR Biosciences, the investigative and exploratory toxicology company, is co-presenting six posters at the upcoming Society of Toxicology meeting in New Orleans on 13th – 17th March.  This innovative research has been performed with several CXR customers including BASF, Adama, Monsanto and the H4R REACH consortium. Four posters describe studies performed at CXR to investigate […]